SimulativeBio during JPM 2026

infinitusbio-AI

Explore pharma's decision-making platform across the entire drug R&D process

PricewaterhouseCoopers LLP

Thank you for registering for SimulativeBio@JPM 2026. 

We’re excited to welcome you and look forward to meeting you at the event!

Join us at SimulativeBio during JPM 2026 hosted by PriceWaterHouseCoopers.2025 was a year of tremendous enthusiasm in the possibilities of leveraging generative AI. We believe 2026 will be the year where alternative approaches in AI will gain momentum to overcome the limitations in generative AI to solve complex scientific challenges such as the innovation necessary within drug development.SimulativeBio is a community dedicated to advancing “Simulative AI”, creating Domain-specific Simulative Models (DsSM) of biology that enhance and extend scientists’ problem‑solving capabilities from target discovery through clinical trials and approval.We are excited to bring together a great panel of experts across drug development, AI, regulatory, data science, and commercial execution to discuss how Simulative AI could be the only viable approach to handle the complexity of biology at scale. SimulativeBio on <a href="https://www.linkedin.com/groups/16591061/" title="https://www.linkedin.com/groups/16591061/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">LinkedIn</a>SimulativeBio on <a href="https://x.com/simulativebio/" title="https://x.com/simulativebio/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">X</a>SimulativeBio on <a href="https://instagram.com/simulativebio" title="https://instagram.com/simulativebio" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">Instagram</a>

Agenda

Registration and Networking

What is Simulative AI? How can Pharma benefit from it?

Partner Presentations

Moderated by Jay Srivinivasan, Executive Chairman at infinitusbio.AI. Panelists: AmiraAli Kia, PhD (VP AI & Data at Element Biosciences), Stephane Altaba, PhD (CEO at Oncovita),  Niranjan Sardesai, PhD (CEO at Geneos Therapeutics), Ian Bales (Director Life Science at PwC), and Khai Minh Pham, MD, PhD (AI) (CEO at infinitusbio.AI).

	Interactive Panel

Cocktails and Networking

Our {communityGuidelinesLink} describe the sort of content we prohibit on Eventbrite. If you suspect an event may be in violation, you can report it to us so we can investigate.

To report other categories of prohibited or illegal content, submit {link}

Ticket sales have ended

SimulativeBio during JPM 2026

More events from infinitusbio-AI

Discover more events from infinitusbio-AI, from Science & Tech to other experiences you might love.

Ticket sales have ended

SimulativeBio during JPM 2026

More events from infinitusbio-AI

Discover more events from infinitusbio-AI, from Science & Tech to other experiences you might love.

You might also like...

Browse more events with different dates, prices, and formats to find your next great experience.